Cargando…
CLL and COVID-19: light at the end of the tunnel?
Autores principales: | Scarfò, Lydia, Herishanu, Yair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352187/ https://www.ncbi.nlm.nih.gov/pubmed/35925645 http://dx.doi.org/10.1182/blood.2022017071 |
Ejemplares similares
-
Vaccination against COVID-19: a challenge in CLL
por: Eichhorst, Barbara
Publicado: (2021) -
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report
por: Cuneo, Antonio, et al.
Publicado: (2020) -
Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022) -
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
por: Roeker, Lindsey E., et al.
Publicado: (2021) -
COVID-19 in patients with CLL: how can we change the odds?
por: Herishanu, Yair, et al.
Publicado: (2021)